Table 3 (abstract ABS015) Cohort comparison for a negative stress echocardiogram result
From: Abstracts from the British Society of Echocardiography annual meeting 2023
Negative stress echo | Group 1/2 (N = 5586) | Group 3 (N = 4853) | P-value |
|---|---|---|---|
Participant demographics | |||
Male (%) | 3020/5586 (54.1) | 2701/4853 (55.7) | 0.10 |
Median age (years) (IQR) | 65 (56–73) | 65 (56–73) |  |
Median BMI (kg/m2) (IQR) | 28.2 (24.95–31.83) | 28.2 (25.07–31.71) |  |
Current smoker (%) | 644/5393 (11.9) | 566/4697 (12.1) | 0.87 |
Ex-smoker (%) | 2018/5393 (37.4) | 1555/4697 (33.1) | < 0.001 |
Non-smoker (%) | 2731/5393 (50.6) | 2576/4697 (54.8) | < 0.001 |
Hypertension (%) | 2626/5586 (47.0) | 2488/4843 (51.4) | < 0.001 |
Hypercholesterolaemia (%) | 2100/5586 (37.6) | 2220/4843 (45.8) | < 0.001 |
Diabetes mellitus (%) | 1054/5586 (18.9) | 994/4843 (20.5) | < 0.05 |
Peripheral vascular disease (%) | 147/5586 (2.6) | 70/4841 (1.4) | < 0.001 |
Family history of premature CAD (%) | 399/5586 (7.1) | 1605/4843 (33.1) | < 0.001 |
Previous MI (%) | 835/5493 (15.2) | 791/4841 (16.3) | 0.11 |
Previous PCI (%) | 1594/5505 (29.0) | 945/4841 (19.5) | < 0.001 |
Precious CABG (%) | 322/5516 (5.8) | 285/4841 (5.9) | 0.91 |
Resting RWMA (%) | 537/5575 (9.6) | 417/3979 (10.5) | 0.17 |
Stress echocardiogram details | |||
Exercise (%) | 1641/5586 (29.4) | 1919/4735 (40.5) | < 0.001 |
Pacemaker (%) | 11/5586 (0.2) | 18/4735 (0.4) | 0.08 |
Dobutamine (%) | 3960/5586 (70.9) | 2798/4735 (59.1) | < 0.001 |
Atropine use in DSE (%) | 1949/3960 (49.2) | 1224/2798 (43.7) | < 0.001 |
Contrast used | 4007/5569 (72.0) | 3938/4805 (82.0) | < 0.001 |
SonoVue (%) | 3667/4007 (91.5) | 3071/3938 (78.0) | < 0.001 |
Luminity (%) | 328/4007 (8.2) | 864/3938 (21.9) | < 0.001 |
Other (e.g. Optison) (%) | 12/4007 (0.3) | 3/3938 (0.1) | < 0.05 |
No contrast (%) | 1562/5569 (28.0) | 867/4805 (18) | < 0.001 |